Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Specialty Chemicals grew 38% YoY for FY23
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
